El-Kawy OA1, Talaat HM1.
J Labelled Comp Radiopharm. 2016 Feb;59(2):72-7. doi: 10.1002/jlcr.3368. Epub 2016 Jan 4.Hepatocellular carcinoma is a widely prevalent cancer, and hence, the development of radiopharmaceuticals for its management is an important issue. In the current investigation, the complexation of idarubicin with (186) Re was studied. Optimum labelling conditions were found to be 4 mg idarubicin, 1.5 mg stannous chloride dihydrate and ~70 MBq Re-186 at pH 7. The complex showed ~97.6% RCY value at 20 min and remained stable up to 24 h in the presence of 2. Read More